Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Intelligent Bio Solutions (INBS)
NASDAQ:INBS
Intelligent Bio Solutions (INBS) Stock Price & Analysis
197 Followers
INBS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.28 - $44.88
Previous Close$2.34
Volume44.10K
Average Volume (3M)97.00K
Market Cap
$6.95M
Enterprise Value$7.13M
Total Cash (Recent Filing)$1.12M
Total Debt (Recent Filing)$1.08M
Price to Earnings (P/E)-0.6
Beta2.55
Next Earnings
Nov 06, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.79
Shares Outstanding3,117,049
10 Day Avg. Volume81,188
30 Day Avg. Volume97,000
Standard Deviation0.64
R-Squared0.14
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)-4.72
Price to Sales (P/S)5.80
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.32
Enterprise Value/Gross Profit21.83
Enterprise Value/Ebitda-0.59
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Intelligent Bio Solutions News
Ownership Overview
39.93% Insiders
0.24% Mutual Funds
24.68% Other Institutional Investors
35.15% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
INBS FAQ
What was Intelligent Bio Solutions’s price range in the past 12 months?
Intelligent Bio Solutions lowest stock price was $2.28 and its highest was $44.88 in the past 12 months.
What is Intelligent Bio Solutions’s market cap?
Currently, no data Available
When is Intelligent Bio Solutions’s upcoming earnings report date?
Intelligent Bio Solutions’s upcoming earnings report date is Nov 06, 2024 which is in 174 days.
How were Intelligent Bio Solutions’s earnings last quarter?
Intelligent Bio Solutions released its earnings results on May 08, 2024. The company reported -$1.43 earnings per share for the quarter, missing the consensus estimate of -$0.87 by -$0.56.
Is Intelligent Bio Solutions overvalued?
According to Wall Street analysts Intelligent Bio Solutions’s price is currently Overvalued.
Does Intelligent Bio Solutions pay dividends?
Intelligent Bio Solutions does not currently pay dividends.
What is Intelligent Bio Solutions’s EPS estimate?
Intelligent Bio Solutions’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Intelligent Bio Solutions have?
Intelligent Bio Solutions has 3,117,049 shares outstanding.
What happened to Intelligent Bio Solutions’s price movement after its last earnings report?
Intelligent Bio Solutions reported an EPS of -$1.43 in its last earnings report, missing expectations of -$0.87. Following the earnings report the stock price went down -13.495%.
Which hedge fund is a major shareholder of Intelligent Bio Solutions?
Among the largest hedge funds holding Intelligent Bio Solutions’s share is Gotham Asset Management LLC. It holds Intelligent Bio Solutions’s shares valued at N/A.
---
Intelligent Bio Solutions Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
INBS Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 40.0 Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.0%
Last 30 Days ▼ 3.8%
Last 30 Days ▼ 3.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-93.43%
12-Months-Change
Fundamentals
Return on Equity
-116.92%
Trailing 12-Months
Asset Growth
59.71%
Trailing 12-Months
Company Description
Intelligent Bio Solutions
Glucose Biosensor Systems (Greater China) Holdings Inc is a United States based company engaged in manufacturing of Saliva Glucose Biosensor (SGB). SGB uses saliva to measure glucose non-invasively. The Saliva Glucose Test consists of the SGB which is a single use disposable saliva biosensor and the software app that interfaces the SGB with its digital information system.
---
Technical Analysis
Aptose Biosciences
―
Advaxis
―
Axonics Modulation Technologies
―
Allogene Therapeutics
―
---